India CAR T Cell Therapy Market: Clinical Trials, Regulatory Pathways, and Potential for Oncology Treatment
The India CAR T Cell Therapy Market is currently in its nascent but highly promising stage, representing a significant leap in the country's capabilities in advanced oncology treatment and cell-based regenerative medicine. CAR T-cell therapy, a revolutionary form of immunotherapy where a patient's T-cells are genetically modified to attack cancer cells, is being developed primarily for hematological malignancies like certain lymphomas and leukemias. The market's potential is enormous, given the high burden of cancer and the need for novel, effective treatments.
18 Views